Curcumin prevents high glucose-induced stimulatory effects of renal cell secretome on fibroblast activation via mitigating intracellular free radicals and TGF-β secretion

Biomed Pharmacother. 2024 May:174:116536. doi: 10.1016/j.biopha.2024.116536. Epub 2024 Apr 2.

Abstract

Diabetic kidney disease (DKD) is a leading cause of kidney failure. However, the involvement of renal fibroblasts and their communications with renal epithelial cells during DKD remain poorly understood. We investigated the potential role of renal proximal tubular epithelial cells (PTECs) in renal fibroblast activation that might lead to DKD. Additionally, the protective effects of curcumin, a known antioxidant, against renal fibroblast activation induced by high glucose-treated PTECs were investigated. Secretome was collected from HK-2 PTECs under normal glucose, high glucose, high glucose pretreated/cotreated with curcumin, or osmotic control condition for 24 h. Such secretome was then used to treat BHK-21 renal fibroblasts for 24 h. BHK-21 cells treated with high glucose-induced secretome had increased levels of fibroblast activation markers, including spindle index, F-actin, α-smooth muscle actin (α-SMA), fibronectin, collagen I, matrix metalloproteinase-2 (MMP-2) and MMP-9, as compared with normal glucose and osmotic control conditions. However, all these increases were successfully mitigated by curcumin. In addition, high glucose markedly increased intracellular reactive oxygen species (ROS) and transforming growth factor-β (TGF-β) secretion, but did not affect the secretion of platelet-derived growth factor A (PDGFA) and interleukin-1β (IL-1β), in HK-2 renal cells as compared with normal glucose and osmotic control conditions. Both intracellular ROS and secreted TGF-β levels were successfully mitigated by curcumin. Therefore, curcumin prevents the high glucose-induced stimulatory effects of renal cell secretome on fibroblast activation, at least in part, via mitigating intracellular ROS and TGF-β secretion.

Keywords: Cytokines; Diabetes; Diabetic kidney disease; Fibrogenesis; Oxidative stress; Renal fibrosis.

MeSH terms

  • Animals
  • Antioxidants / pharmacology
  • Cell Line
  • Curcumin* / pharmacology
  • Diabetic Nephropathies / metabolism
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Fibroblasts* / drug effects
  • Fibroblasts* / metabolism
  • Glucose* / toxicity
  • Humans
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / metabolism
  • Reactive Oxygen Species* / metabolism
  • Secretome / drug effects
  • Secretome / metabolism
  • Transforming Growth Factor beta* / metabolism

Substances

  • Curcumin
  • Glucose
  • Transforming Growth Factor beta
  • Reactive Oxygen Species
  • Antioxidants